Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Repurchased (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Shares Repurchased data on record, last reported at $20.5 million in Q4 2025.

  • For Q4 2025, Shares Repurchased fell 51.15% year-over-year to $20.5 million; the TTM value through Dec 2025 reached $75.6 million, down 40.46%, while the annual FY2025 figure was $75.6 million, 11.55% down from the prior year.
  • Shares Repurchased reached $20.5 million in Q4 2025 per AMPH's latest filing, up from $4.8 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $50.0 million in Q3 2023 and bottomed at $128000.0 in Q2 2023.
  • Average Shares Repurchased over 5 years is $16.4 million, with a median of $11.0 million recorded in 2025.
  • The widest YoY moves for Shares Repurchased: up 552.16% in 2023, down 97.91% in 2023.
  • A 5-year view of Shares Repurchased shows it stood at $13.4 million in 2021, then surged by 34.48% to $18.1 million in 2022, then skyrocketed by 176.72% to $50.0 million in 2023, then fell by 16.0% to $42.0 million in 2024, then tumbled by 51.15% to $20.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $20.5 million in Q4 2025, $4.8 million in Q3 2025, and $39.2 million in Q2 2025.